Among over 500 obese patients with OSAS, long-term tirzepatide treatment led to significant reductions in body weight, AHI, and oxygen desaturation index, with particularly pronounced benefits in patients with concurrent glucose and lipid metabolism abnormalities (52)
The degree of weight loss achieved also matterspatients who reach a healthy weight range and maintain it for an extended period while on medication may attempt discontinuation differently than those who achieve modest weight reduction
Serious side effects, warnings, and precautions Wegovy may also cause serious side effects, including inflammation of the pancreas (pancreatitis) and gallbladder problems
This is because GLP-1 has a short half-life in the body (e.g
The circumventricular organs, including the area postrema, lack a complete blood-brain barrier, allowing circulating GLP-1 and GLP-1 receptor agonists more direct access to these critical regulatory centers
A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol